Robert I. Liem, MD

Director, Comprehensive Sickle Cell Program

Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Language: English

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Sickle cell disease, hereditary spherocytosis, thalassemia and general hematology

Specialties, Programs & Conditions

Specialties:

Hematology & Oncology

Programs & Conditions:

Sickle Cell Disease Program

Education & Training

Education: Northwestern University, 1997,

Postgraduate Training: Fellowship in pediatric hematology/oncology, Johns Hopkins Hospital and the National Cancer Institute, 2001-2004; Chief resident, 2000-2001, and resident, pediatrics, Children's Memorial Hospital, 1997-2000

Board Certifications: Pediatric Hematology-Oncology, General Pediatrics

See Northwestern University Faculty Profile >

Research

Research Interests: Sickle cell disease; exercise physiology; health disparities

Northwestern Scholars Profile >

Publications

Most recent publications

Nucleated Red Blood Cells in Children With Sickle Cell Disease Hospitalized for Pain J Pediatr Hematol Oncol
Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease Pediatr Hematol Oncol1-12
Balancing exercise risk and benefits: lessons learned from sickle cell trait and sickle cell anemia Hematology Am Soc Hematol Educ Program2018 (1): 418-425
Exercise Capacity and Clinical Outcomes in Adults Followed in the Cooperative Study for Sickle Cell Disease (CSSCD) Eur J Haematol
Exercise capacity and clinical outcomes in adults followed in the Cooperative Study of Sickle Cell Disease (CSSCD) Eur J Haematol101 (4): 532-541
Beliefs about hydroxyurea in youth with sickle cell disease Hematol Oncol Stem Cell Ther11 (3): 142-148
Risk Factors for Neonatal Venous and Arterial Thromboembolism in the Neonatal Intensive Care Unit-A Case Control Study J Pediatr19528-32
Hydroxycarbamide in Children with Sickle Cell Anemia After First-dose Vs. Chronic Therapy: Pharmacokinetics and Predictive Models for Drug Exposure Br J Clin Pharmacol
Hydroxycarbamide in children with sickle cell anaemia after first-dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure Br J Clin Pharmacol84 (7): 1478-1485
Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults Health Qual Life Outcomes15 (1): 136

See All

Call for Insurance information: 1.800.543.7362

News

1 Results

Is Exercise Safe for Kids with Sickle Cell Disease?

See all News & Stories >

Robert I. Liem, MD

Robert I. Liem, MD

Director, Comprehensive Sickle Cell Program

Associate Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Specialties, Programs & Conditions

Education & Training

Research

Publications

Call for Insurance information: 1.800.543.7362

Location

News

Is Exercise Safe for Kids with Sickle Cell Disease?